lobbying_activities: 3050803

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3050803	89333959-5d50-4ccd-8811-32d738cd996a	Q3	MCDERMOTT+ LLC	401103287	CAMPAIGN FOR SUSTAINABLE DRUG PRICING	2023	third_quarter	CPT	Patent abuse issues. S. 150 - Affordable Prescriptions for Patients Act of 2023. S. 79 - Interagency Patent Coordination Act. Initiatives To Ensure the Robustness and Reliability of Patents Rights (PTO-P-2022-0025). Joint USPTO-FDA Collaboration Initiatives.	Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Patent & Trademark Office (PTO),SENATE	30000		0	0	2023-10-16T11:10:30-04:00